Qualcomm secures Transsion through 2031. Licensing revenue still points flat

Qualcomm turned a lawsuit into a licence in 2025 and renewed it through 2031 in October 2026. Fiscal 2026 licensing revenue is guided to $5.45 billion to $5.65 billion, with a midpoint below last year. The deal adds duration, not growth.

Qualcomm's patent licensing arm earns about $5.6 billion a year at a 72% margin. That income depends on a short list of phone makers continuing to sign. On 16 October, Qualcomm said it had signed a long-term renewal of its global patent licences with Transsion Holdings. The renewal covers 4G and 5G devices through the end of 2031 and came 11 days after Qualcomm announced a broad licence with Huawei.

The renewal buys Qualcomm time rather than growth. No royalty rate or payment was disclosed, so the licensing revenue line is the only test of the deal's worth. That line is slipping.

The history of the deal is the stronger story. In its fiscal 2024 annual report, Qualcomm described a licence with Transsion "for its 5G products". Transsion is a China-headquartered phone maker that sells mainly in developing regions. Qualcomm was still negotiating a comprehensive resolution and had started litigation in multiple jurisdictions over unlicensed products.

That changed within months. By the quarter ended 30 March 2025, Qualcomm had signed comprehensive 4G and 5G licences with Transsion. All outstanding litigation between the parties had been dismissed. That quarter's revenue already included estimated royalties due from Transsion for March 2025 sales.

Transsion went from defendant in several courts to licensee within months. Qualcomm has now extended that agreement early, 19 months after the March 2025 licence, to more than five years. A licence signed under legal pressure was renewed before it was due. That is a win on duration: it removes a renewal date from 2026 and pushes the next licence cliff far off.

Duration alone does not lift revenue, and the record shows it. QTL, Qualcomm's technology licensing segment, booked $5,306 million in fiscal 2023 and $5,572 million in fiscal 2024. It then booked $5,582 million in fiscal 2025, a gain of just 0.2% after 5.0% growth the year before. Pre-tax margin was 72% in both of the last two years. Those figures leave out $143 million from an unnamed dispute settlement in the second quarter of fiscal 2025. The annual report does not allocate that licensing revenue to any segment.

The current year is weaker. In the quarter to 28 June 2026, QTL revenue fell 3% to $1,278 million. Nine-month revenue stands at $4,252 million, up 1.9%. Qualcomm blamed a $67 million drop on fewer estimated sales of cellular products and a $25 million drop on lower royalties for prior-period devices. Higher revenue per unit added back $59 million. Falling volume offset by rising price is how a mature royalty stream looks.

Profit followed revenue down in the quarter. QTL pre-tax profit fell 6% to $881 million. The margin eased to 69% from 71%, although the nine-month margin is 73%. A licensing business has a fixed cost base, so a flat top line shows up first in its margin. That is why the 72% margin of fiscal 2025 may not hold in fiscal 2026.

The company's guidance points the same way. Qualcomm expects $1.2 billion to $1.4 billion for the September quarter. The $1.3 billion midpoint is about 8% below the $1,409 million of the same quarter a year earlier. That quarter had itself fallen 7% from $1,521 million a year before. Added to nine months of actuals, that puts fiscal 2026 between $5.45 billion and $5.65 billion. The range straddles last year's $5,582 million, so flat is the best case, and the $5.55 billion midpoint, a CTOL calculation, sits slightly below it. Transsion was already paying this year, so its licence holds the base in place without lifting it.

Huawei is the missing part of that base. Qualcomm's annual report says QTL revenue stopped including Huawei royalties from the second quarter of fiscal 2025 because the licence had expired. A lapsed agreement therefore costs recorded revenue until a new one replaces it. The Huawei announcement describes a multi-year agreement with cross licences across 5G, compute, AI, and networking. It also includes Qualcomm's purchase of certain Huawei U.S. patents, and only that purchase closes after regulatory approvals.

Within 11 days, Qualcomm renewed one licensee early and signed a new agreement with an expired one. Neither deal has yet shown up as higher recorded revenue, and fiscal 2026 will end without either one adding to it. The Huawei licence is the bigger source of upside because Qualcomm has recorded no Huawei royalties since early fiscal 2025. The Transsion renewal protects revenue Qualcomm already collects.

The size of the gap shows why the missing growth matters. Each 1% of QTL revenue is about $56 million a year, or $40 million of pre-tax profit at a 72% margin. Growth needs a higher rate, more licensed phones, or Huawei royalties. Transsion adds none because it was already paying.

Qualcomm's fourth-quarter release in early November 2026 is the nearer checkpoint. It will show whether September-quarter licensing revenue beat the $1.3 billion midpoint, and its December-quarter guide will show whether Huawei has started to add. CTOL expects fiscal 2027 licensing revenue, reported in November 2027, to finish above $5.65 billion, the top of this year's range. A full year of Huawei royalties should outweigh slow erosion elsewhere while Transsion holds steady. The quarterly guide is the first hard read on whether the slide has stopped, so it matters more than a press release. A December-quarter guide below $1.3 billion would put that call in doubt.